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Double knockouts of the Msx1 and Msx2 genes in the mouse result in severe cardiac outflow tract malformations similar to those frequently
found in newborn infants. Despite the known role of the Msx genes in cardiac formation little is known of the regulatory systems (ligand receptor,
signal transduction and protein–DNA interactions) that regulate the tissue-specific expression of the Msx genes in mammals during the formation
of the outflow tract. In the present study we have used a combination of multi-species comparative genomics, mouse transgenic analysis and
in-situ hybridisation to predict and validate the existence of a remote ultra-conserved enhancer that supports the expression of the Msx1 gene in
migrating mouse cardiac neural crest and the outflow tract primordia. Furthermore, culturing of embryonic explants derived from transgenic
lines with agonists of the PKC and PKA signal transduction systems demonstrates that this remote enhancer is influenced by PKA but not PKC
dependent gene regulatory systems. These studies demonstrate the efficacy of combining comparative genomics and transgenic analyses and
provide a platform for the study of the possible roles of Msx gene mis-regulation in the aetiology of congenital heart malformation.
© 2008 Elsevier Inc. All rights reserved.Keywords: Msx1 gene; Comparative genomics; Transfac; Enhancer element; Transgenic mouse; Embryo; Cardiac neural crest; Outflow tract; Transcription; PKAIntroduction
Proper morphogenesis of the outflow region relies on the
ventral migration of a population of cells called the cardiac
neural crest (cNC) (Jiang et al., 2000). Ablation of cNC cells
derived from embryonic hindbrain rhombomeres 6, 7, and 8 in
chick embryos resulted in a series of outflow tract defects that
are frequently found in newborn human infants (Waldo et al.,
1999, 2005). These cNC cells contribute to the formation of the
endocardial cushions of the outflow tract that subsequently
forms the conotruncal septum that, in turn, divides the aortic and
pulmonary channels and contributes to the heart valves and the
upper portions of the intraventricular septum (Kirby and Waldo,
1995). A class of homeobox genes called the muscle segment
homeobox (Msx) genes are expressed in migrating cNC (Chan-⁎ Corresponding author.
E-mail address: mbi167@abdn.ac.uk (A. MacKenzie).
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doi:10.1016/j.ydbio.2008.02.016Thomas et al., 1993; Houzelstein et al., 1997) and have recently
been shown to be critical in normal morphogenesis of the
outflow tract as deletions of the Msx1 and Msx2 genes cause
extensive outflow tract defects that reflect those frequently seen
in newborn human infants (Ishii et al., 2005; Lallemand et al.,
2005; Ogi et al., 2005). Although these genes have been shown
to be critical to formation of the outflow tract virtually nothing
is known of the regulatory systems that coordinate and support
the tissue-specific expression of these genes in cardiac neural
crest or outflow tract. The reasons for this lack of knowledge
stems from a previous inability to accurately predict the
location, functional linkage and tissue-specific characteristics
of key regulatory sequences that may possibly be located at
some distance from the genes they regulate.
The current study describes the use of multi-species
comparative genomics and Transfac bioinformatics to predict
the location and tissue-specific characteristics of a novel enhancer.
The status of this enhancer as a cNC specific enhancer of the
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transgenic embryo studies and in-situ hybridisation. In addition to
predicting and validating many of its characteristics we also
demonstrate, using transgenic embryonic explant culture, that this
enhancer is responsive to PKA but not PKC signalling strongly
suggesting the role of a PKA mediated signal transduction
pathway in the regulation of Msx1 in cNC cells.
The prediction and validation of the tissue-specific proper-
ties of this highly conserved cNC specific enhancer demon-
strates the power of using predictive multi-species comparative
genomics in facilitating an understanding of the regulatory
systems controlling the expression of clinically important
genes. Furthermore, the discovery of this ultra-conserved
functional enhancer element will serve as a platform for
understanding the possible effects of gene mis-regulation in the
production of cardiac outflow tract defects and lends greater
weight to the assertion that, in addition to mutations of coding
regions, regulatory regions should be examined when attempt-
ing to determine the roles of key genes in the production of
developmental malformations and disease.
Methods
Bioinformatic analysis
Comparative genomic analysis of non-coding DNA surrounding the Msx1
gene was carried out using the ECR browser (http://ecrbrowser.dcode.org)
(Ovcharenko et al., 2004). Verification of transcription factor binding matrices
was carried out using TRANSFAC professional (BIOBASE Biological
Databases) (Matys et al., 2003, 2006).
Plasmid constructs
p1230/KE— Primers KE.for; TAT GTT TAG CCC ACC CTG GA and KE.
rev; TGA GGC TGG CCTATC TGA CT were used to amplify the Human KE
element from human placental DNA (Sigma) using a high fidelity polymerase
(Expand HiFi system, Roche) and annealing temperature of 57 °C. The PCR
product was digested with enzymes EcoRI and SpeI, and ligated into compatible
ends of plasmid pGEM-7Zf (+) (Promega) to produce pGEMKE. The KE insert
from pGEMKE was removed by digestion with SphI (made blunt end using
Klenow enzyme) and then with KpnI. This fragment was then ligated into the
HindIII (made blunt end using Klenow enzyme) and KpnI restriction sites of
the pBGZ40–1230 LacZ reporter plasmid (Yee and Rigby, 1993) to form p1230/
KE. p1230/KE was linearised and released from the plasmid backbone using
KpnI and NotI prior to pronuclear injection.
Pronuclear injection
Pronuclear microinjection of 1-cell mouse embryos was performed as
previously described (Nagy et al., 2003). Briefly, linearised p1230/KE DNA at a
concentration of 2 ng/μl was injected into the pronucleii of 1 cell embryos
derived from superovulated and mated (CBA×c57BL/6)F1 females. Surviving
eggs were transferred into the oviducts of CD1 pseudo pregnant mice.
Detection of transgene activity
After dissection from extra-embryonic tissue in room temperature PBS,
embryos were washed briefly in standard wash (2 mMMgCl2 in PBS) and fixed
in 4% paraformaldehyde (PFA) at 4 °C for 1 h. Embryos were washed using
detergent wash (2 mMMgCl2, 0.1% sodium deoxycholate, 0.02% Nonidet P-40
and 0.05% BSA in 0.1 M phosphate buffer (pH 7.3) for 3×20 min at room
temperature. Embryos were transferred to X-gal stain (0.085% NaCl2, 5 mM
K3Fe (CN)6, 5 mM K4Fe (CN)6 and 0.1% 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal); Melford Laboratories) and incubated at 37 °C for 2 h
to overnight. After staining, embryos were transferred to 4% PFA at 4 °C
overnight and stored in 100% methanol at −20 °C.
In-situ hybridisation
Plasmid pGEM7/Msx1 was linearised with NsiI for production of antisense
probe. Digoxygenin (DIG) labelled antisense probes were transcribed using
components of the T7 RNA polymerase Maxiscript In Vitro Transcription Kit
(Ambion) as described in the manufacturers instructions with the following
modifications. DIG labelled antisense RNA probes were transcribed in the
following reaction; 1× transcription buffer, 0.01 M DTT, 2 mM rNTP mix
(0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.32 mM UTP and 0.18 mM dig-
UTP; (Roche)), 5 μg linearised template plasmid DNA, 40 units RNAase
inhibitor, RNAasin (Roche) and 90 units of the T7 RNA polymerase in
nuclease-free water to a final volume of 50 μl. Whole-mount in-situ
hybridisation with fresh embryos was carried out as previously described
(Lettice et al., 2002).
Immunohistochemistry
Embryonic tissue was fixed in 4%PFA for 1 h and left overnight in 20%
OCT medium. Embryos were then orientated within pure OCT medium and
frozen. Sections were cut at −30 °C using in a Hacker Bright Clinicut cryostat
and sections were mounted on Polysine-coated slides (VWR). Sections were
washed in Tris Buffered Saline (TBS) for 5 min then treated with 1% sodium
dodecyl sulfate (SDS) solution in TBS for 5 min to facilitate antigen recovery.
Slides were then washed four times for 5 min in TBS with gentle rocking. The
slides were then transferred to a humidified chamber and samples were pre-
incubated with TBST (TBS plus 0.1% TritonX-100 at pH 7.5) containing 10%
Fetal Calf Serum (FCS) for 10 min, at room temperature, to suppress non-
specific binding of the antibody. The samples were washed in TBST 3 times for
5 min with gentle rocking. Consecutive sections were separately incubated with
primary antibodies Anti-Msx1/2 (Hybridoma Bank) and 40-1a (anti-β-
galactosidase; Hybridoma Bank) at a dilution of 1:20 in TBST/10% FCS.
After overnight incubation in a humidified chamber, unbound antibody was
removed from samples by washing 3×5 min in TBST with gentle rocking. All
samples, including control, were then incubated in the dark with secondary
antibody (1:200, Alexa Fluor Rabbit anti-mouse IgG 594; Molecular Probes/
Invitrogen) for 1 h at room temperature. The slides were then washed in TBST
3×5 mins with gentle shaking. Slides were then mounted in VECTASHIELD®
mounting medium with DAPI (Vector labs) and visualised immediately with an
Axioskop 2 plus microscope (Zeiss) with HBO100 FluoArc mercury lamp and
GFP filters. Images were analysed using Axiovision Viewer 3.0 imaging
software.
Vibratome sectioning
For vibratome sectioning embryos were fixed in 4% paraformaldehyde
(PFA)/PBS from 1 h to overnight at 4 °C. Embryos were equilibrated through
4% and 20% sucrose/PBS solutions at 4 °C for several hours or until the
embryos had sunk. Embryos were then transferred to BSA/gelatin mix (0.5%
gelatin, 1% BSA and 5% sucrose in PBS) overnight or longer. Prior to
embedding, embryos were removed from BSA/gelatin and excess mix removed
by blotting. Embryos were fixed in 25% glutaraldehyde for no longer than 1 min
and embedded in BSA/gelatin containing 0.25% glutaraldehyde. Blocks
containing embryos were then prepared for sectioning by gluing the block to
the cutting dish using cyanoacrylate based adhesives. Sections of 50 μm were
taken at speed 2–10, amplitude 8 on a Lancer Vibratome series 1000. Sections
were floated onto a SuperFrost microscope slide (VWR) and mounted in
aqueous mountant (7% gelatin, 50% glycerol and 0.1% phenol in water).
Transgenic explant agonist studies
Embryonic day 10.5 (E10.5) transgenic embryos were recovered and
divided in half transversely at a level posterior to the heart primordium in ice-
cold PBS. Transgenic anterior halves were then divided sagitally using a sterile
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posterior halves. AG-1X2-formate beads (a gift from Cheryl Tickle) were
soaked for 1 h in either the adenylyle cyclase agonist forskolin (100 μM) or the
PKC agonist phorbol dibutyrate (PDBu; 1 μg/ml) in dimethyl sulfoxide
(DMSO). These beads were then implanted within the otic vesicles of transgenic
explants. Head explants were cultured on Millicell Culture Plate Inserts
(Millipore) with D-MEM medium supplemented with 2 mM GlutaMAX
(Invitrogen), 100 U/ml penicillin, 100 μg/ml streptomycin (Invitrogen) and 10%
Fetal Bovine Berum (FBS; Biosera) for 24 h at 37 °C/5% CO2. Alternatively,
either forskolin or PDBu were added to the medium at concentrations of
10 μM and 100 ng/ml respectively. In each case similar quantities of DMSO
without the addition of agonists were added to control halves of the same head.
Following incubation for 24 h agonist effects were assessed by X-gal staining
for 6 h. X-gal staining was stopped by multiple washes in PBS and 1 h fixation
in 4% paraformaldehyde (PFA)/PBS at 4 °C.Results
Comparative genomic analysis reveals a highly conserved
non-coding sequence preserved in-cis with Msx1 for 450
million years
In order to determine the location and identity of a possible
cNC specific MSX1 enhancer we used the ECR browser to
undertake a comparative genomic analysis of theMSX1 flanking
regions covering 100 kb in both a 5′ and a 3′ direction with
reference to the human MSX1 locus. We compared the flanking
sequences of the MSX1 locus to 8 other vertebrate species
spanning 450 million years of vertebrate evolution (Blair Hedges
and Kumar, 2003) (Fig. 1A). Although comparison of humanFig. 1. (A) A multispecies rVISTA plot from the ECR browser comparing 50 kb of hu
top to bottom) zebrafish (Zeb.), puffer fish (Fugu), Xenopus (Xen.), chicken (Chick),
reference to the human genome sequence. The scale bar represents 4 kb compared to
represents levels of sequence conservation between 50% and 100%. Red, blue, pink
100 base pairs in intergenic non-coding, exonic, intronic and 3′ and 5′ untranslated re
sequence including LINEs, SINES and Alu sequences. Previously described enhance
distal enhancer (DE; MacKenzie et al., 1997; Miller et al., 2007). KE is also highlig
marsupial (monodom), chicken, frog, fugu and tetradon (tetra) KE enhancer sequence
for vertebrates). Putative transcription factor binding sites as predicted by TRANSF
areas of coloured sequence above each of the lines of sequences. A key for each of t
S8 is also known as Prx2.sequence with more diverged non-mammalian genomes such as
that of chicken significantly reduced the numbers of these
conserved sequences, it had the effect of greatly increasing the
accuracy of prediction. This was highlighted by the accurate
verification of previously characterised enhancer elements (PE
andDE, see Fig. 1A) (MacKenzie et al., 1997;Miller et al., 2007).
Furthermore, accurate prediction of an active and Wnt inducible
TCF4 binding site within PE was previously possible using a
combination of comparative genomics and transfac analysis
(Miller et al., 2007). In addition to the PE and DE elements the
presence of a significant area of non-coding conservation over
40 kb 5′ of the Msx1 transcriptional start site was highlighted.
This highly conserved sequence, that we called KE, continued to
be highly conserved even in amphibians and fishes suggesting its
critical role in some biological process common to all vertebrates.
A clue to its possible purpose came from the observation that in all
of the species analysed, KEwas always maintained in ciswith the
Msx1 gene. Considering the known high rate of genomic
rearrangement events known to occur during evolution, the
continued retention of KE in synteny with the Msx1 gene over
450 million years of evolution strongly suggests that KE is
functionally linked to the Msx1 gene (Mackenzie et al., 2004).
Furthermore, recent studies have shown that over 75% of non-
coding sequences demonstrating similar degrees of conservation
consist of tissue-specific cis-regulatory elements such as
enhancers (Pennacchio et al., 2006). We therefore explored the
hypothesis that this sequence was a tissue-specific enhancer
required for some aspect of the regulation of the MSX1 gene.man genomic flanking sequence 5′ of theMsx1 transcriptional start site to (from
Marsupial (Mars.), rat, mouse and dog. The x-axis represents linear distance with
the human genome sequence that has been used as the base sequence. The y-axis
and yellow peaks represent areas of sequence conserved for more that 75% over
gions (UTR) respectively. Green bars and grey boxes represent areas of repetitive
rs are highlighted in black boxes and include the proximal enhancer (PE) and the
hted within a black box. (B) A linear alignment of the human, dog, mouse, rat,
s demonstrating levels of conservation (highlighted in pink for tetrapods and red
AC professional (matrix similarity≥0.90, core similarity=1) are highlighted as
he transcription factor binding sites is displayed in the bottom right hand corner.
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conserved binding sites for transcription factors specific to
neural crest and heart cell lineages
In order to predict the possible tissue-specific properties of
KE we carried out a Transfac analysis on the sequence using
high search stringencies (core=1, matrix N0.9). We were able to
detect the nearly perfectly conserved putative binding consensii
of a number of neural crest (Sox5 and Sox9) (Perez-Alcala et al.,
2004; Sakai et al., 2006) and heart specific (GATA, NKX2.5, S8
(Prx2)) (Durocher et al., 1997; Leussink et al., 1995) trans-
cription factors (see Fig. 1B). This observation was consistent
with the hypothesis that KE was an MSX1 cardiac neural crest
specific enhancer.
KE is a tissue-specific enhancer and supports transgene
expression within Msx1 expressing cNC
In order to validate our hypothesis that KE represented a
cNC specific enhancer sequence we amplified and isolated the
human KE from human placental DNA. The KE sequence was
then cloned into a lacZ reporter construct containing a LacZ
marker gene (pBGZ-1230) fused to a human β-globin minimal
promoter to form the p30KE plasmid. pBGZ-1230 has been
used as a reporter plasmid several times in the past and is
incapable of supporting any degree of consistent tissue-specificFig. 2. (A–F) Whole mount analysis of E8 (A and B), E9.5 (C and D) and E10.5 (E) p
p30KE transgene construct. hb; hindbrain, hf; head fold, dl; dorsal lip, ov; otic vesicl
4–6, pf; pontine flexure. White arrowheads (E) highlight the positions of cells between
transgene.expression (Yee and Rigby, 1993). We linearised the p30KE
plasmid and produced 3 different transgenic mouse lines by
pronuclear injection of 1-cell mouse embryos. In later
development, several differences were observed between
these lines in terms of their staining within limb buds and the
developing nervous system (not shown). These differences were
attributed to integration effects. However, all lines demonstrated
strong and reproducible expression in presumptive neural crest
cells migrating between the embryonic hindbrain region and the
developing heart field in cells surrounding the otic vesicle.
Because of its reproducibility this expression was directly
attributable to the activity of the KE element. Using Xgal
histological staining we analysed the expression of the
transgene throughout the early stages of embryonic develop-
ment from embryonic day 8 (E8) to E12.5. At E8 expression of
the p30KE transgene was strongest in an area of the neural head
fold lip destined to form the hindbrain. Expression of the
transgene also extended ventrally and laterally within the
epiblast (Figs. 2A and B). At E9.5 expression of the transgene
persisted within the dorsal lip of rhombomeres 4 and 6 of the
hindbrain (Figs. 2C and D). In addition LacZ expression was
obvious in 2 different streams of presumptive neural crest cells
migrating from rhombomeres 4 and 6 migrating either side of
the otic vesicle (Fig. 2D). These observations are entirely
consistent with the reported expression of a LacZ based marker
gene used to target the second exon of the Msx1 gene in mice30KE transgenic mouse embryos stained with X-Gal to detect expression of the
e, 1,2,3; brachial arches 1, 2 and 3, ey; optic vesicle, r4, r5 and r6; rhombomeres
the epithelium and neuroepithlium and caudal of the otic vesicle that express the
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marker can clearly be seen in cells migrating from rhombo-
meres 4 and 6 either side of the otic vesicle (Houzelstein et al.,
1997). By E10.5 expression of the transgene was still obvious
within migrating neural crest cells either side of the otic
vesicle (Fig. 2E) that also expressed Msx1 transcripts (Figs.
3A and B). These observations were further verified using
monoclonal antibodies specific to the Msx1 protein (Figs. 3D
and G) and LacZ protein (Figs. 3E and H) that detected both
Msx1 and LacZ within presumptive neural crest derived
mesenchyme cells immediately caudal of the otic vesicle (Figs.Fig. 3. (A) Vibratome section of an E10.5 mouse embryo sectioned coronally through
in-situ hybridisation using a DIG-labelled Msx1 specific anti-sense probe (purple sta
detect expression from the transgene and sectioned coronally through the hindbrain.
clarify the positions of each cell layer. In both panels A and B the rostro-caudal axis
taken at the same level it should be noted that morphological differences between
hybridisation. DAPI stained (C and F), and fluorescent immunohistochemical analysi
bacterial β-galactosidase protein (LacZ; E and H) in adjacent 8 μm cryostat sectio
expression of Msx1 and LacZ is highlighted using white arrow heads and can be seen
3rd branchial artery (3ba; G and H) around which neural crest are known to migrate in
expression (purple stain) within the outflow tract (oft) of an E10.5 wild type embryo he
stained whole mount preparation of an E11.5 embryo heart transgenic for the p1230/KE
using white arrow heads. (K) sectional analysis of X-Gal stained E11.5 embryonic heart
lining the outflow tract (oft). The extent of transgene expression is highlighted using3D and E) and in cells migrating next to the 3rd branchial arch
artery (Figs. 3G and H), a known conduit of cardiac neural
crest migration (Sieber-Blum, 2004). We also examined the
expression of the transgene in the developing heart and were
able to detect LacZ expression within cells lining the outflow
tract previously shown to express Msx1 (Chan-Thomas et al.,
1993) (Figs. 3J and K). However, the expression of the
transgene in the outflow tract was detected at least a day later
than the expression of the Msx1 gene (Figs. 3I–K) and was
not as widespread throughout the outflow tract as previously
reported for Msx1 transcripts.the hindbrain region at the level of the otic vesicle and analysed by whole mount
ining). (B) Vibrotome section of an E10.5 p30KE embryo stained using X-gal to
In both panels A and B tissue layers are delimited using broken white lines to
runs from left (rostral; Rost.) to right (caudal; Caud.). Although the sections are
A and B reflect the different methods used for LacZ staining and for in-situ
s using monoclonal antibodies raised against the Msx1 protein (D and G) and the
ns of an E10.5 mouse embryo transgenic for the p1230/KE plasmid. Cellular
in mesenchyme cells caudal to (D and E) the otic vesicle (ov), and adjacent to the
to the heart field. (I) Whole mount in-situ hybridisation analysis ofMsx1mRNA
art where the extent of expression is highlighted using black arrow heads. (J) X-gal
construct demonstrating transgene expression within the outflow tract, highlighted
transgenic for the p1230/KE construct demonstrating LacZ expression within cells
white arrow heads. at, atrium; NT, neural tube.
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cAMP mediated but not PKC mediated signal transduction
pathways
Transfac analysis of the KE element demonstrated the
presence of several highly conserved putative binding sites of
the Sox9 transcription factor that is known to be expressed
during, and required for, neural crest differentiation and
migration (Kordes et al., 2005). Furthermore, previous studies
have shown that the expression of Sox9 in these neural crest
cells is responsive to PKA signalling (Sakai et al., 2006). In
order to explore the hypothesis that the KE enhancer was
responsive to cAMP mediated PKA signalling, we recovered
E10.5 embryos transgenic for the p30KE transgene and divided
their heads sagittally. These halves were then cultured in the
presence or absence of the adenylyl cyclase agonist forskolin. In
parallel, we also cultured sagittally divided transgenic embryo
heads in the presence of the PKC agonist phorbol 12,13-
dibutyrate (PDBu). Both agonists were applied either to the
medium or were soaked in AG-1X2-formate beads that were
then placed within the otic vesicle of the transgenic embryonic
explant. Following overnight culture the embryo head explants
were fixed and stained for equal periods of time in equal
concentrations of X-gal. Comparisons were made between
PDBu exposed transgenic explants and those not exposed to
PDBu. No discernable difference could be detected in the
staining intensity of either transgenic explant half exposed to
PDBu placed either in the medium or applied using formate
beads (data not shown). However, we were able to discern a
clear and significant change in both in the intensity and
distribution of LacZ staining cells in head explants cultured with
forskolin (see Fig. 4). In the case of the implanted beads
elevated expression of the transgene was clearly evident in cellsFig. 4. (A–H) X-gal stained embryo head explant cultures derived from E10.5 mou
explants that have been implanted with AG-1X2-formate beads soaked in DMSO (A a
(B and D). White arrows highlight position of implanted beads within the otic vesic
containing 100 ng/ml of forskolin in DMSO (F and H) or DMSO only (E and G; msurrounding the bead implantation site to the extent that
discerning the location of the bead was difficult following LacZ
staining (Figs. 4A–D). Furthermore, expression of the trans-
gene was greatly enhanced throughout the explant and extended
into regions surrounding the developing eyes and pharyngeal
arches by addition of forskolin to the medium. These are areas
of expression not previously associated with the activity of the
transgene in the untreated explants (Figs. 4E–H) and clearly
demonstrate that the KE element is responsive to cAMP/PKA
mediated pathways.
Discussion
The high degrees of conservation of regulatory regions that
modulate the expression of developmentally important genes
suggests that control of the expression of these genes has been
at least as important as the function of the proteins they
produced during evolution (Davidson et al., 2006a,b; Mac-
Kenzie and Quinn, 2004; Mackenzie et al., 2004). It has been
realised for a number of years that comparative genomics is an
important tool in the search for sequences within the genome
critical to normal human development and health (Loots and
Ovcharenko, 2005; Loots et al., 2002; Ovcharenko and Loots,
2003; Wasserman et al., 2000; Wei et al., 2002). Although the
primary reason for the sequencing of the human genome, as
well as a number of other vertebrate genomes, was to find
novel genes, it is now obvious that these genome sequences are
also extremely useful in detecting the regulatory elements
responsible for controlling the expression of these genes. In the
present study we have used comparative genomics to locate,
isolate and characterise a highly conserved enhancer element
and provide evidence for the regulatory systems that modulate
its activity.se embryos transgenic for the p1230/KE construct. Panels A–D represent head
nd C; bead −ve) and in DMSO containing a 10 micromolar solution of forskolin
le (ov). Panels E–H represent head explants that have been cultured in medium
edium –ve). v; ventral aspect, d; dorsal aspect, e; eye, 1; first pharyngeal arch.
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dorsal neural tube lip and migrating cNC
The Msx genes have been shown to be critical components of
the mechanisms required for normal formation of the outflow
tract of the heart (Ishii et al., 2005; Lallemand et al., 2005; Ogi et
al., 2005). The current study describes the discovery of a highly
conserved cardiac neural crest specific enhancer, KE, that has
been conserved in cis with the Msx1 gene for over 450 million
years and supports the activity of a marker gene in dorsal neural
tube lip and presumptive cNC cells migrating from the fourth and
sixth hindbrain rhombomeres that also expressMSX1 transcripts
(Houzelstein et al., 1997). In addition, the regulatory systems that
support the tissue-specific properties of this enhancer are cAMP
responsive, suggesting a role for a PKA dependent signal
transduction pathway that may have been conserved from our
fish ancestors. The role of cAMPmediated PKA pathways in the
specification, migration and differentiation of neural crest is well
documented (Benjanirut et al., 2006; Chen et al., 2005; Huber et
al., 2003; Sakai et al., 2006). Furthermore, many of these PKA
mediated regulatory systems include the involvement of
transcription factors such as Sox 5 and 9 (Perez-Alcala et al.,
2004; Sakai et al., 2006). Therefore, our observation that the KE
element is not only cAMP inducible but also contains a
number of perfectly conserved putative Sox transcription factor
binding sites is consistent with our current understanding with
regard to the SoxE/PKA dependent regulatory systems known
to modulate the specification of cardiac neural crest (Perez-
Alcala et al., 2004; Sakai et al., 2006). Thus, our data, in
combination with the published literature, suggests a role for
the KE element in the proper morphogenesis of the heart.
A role for KE in heart morphogenesis
Understanding where KE is important in heart development
necessitates an understanding of the origins and destination of the
cNC. The role of the cardiac neural crest in morphogenesis of the
outflow tract of the heart can be broken down into 3 main steps;
specification, migration and differentiation (Hutson and Kirby,
2003). Defects in the molecular pathways controlling each of
these steps have been shown to result in outflow tract defects.
Specification of the neural crest from the dorsal lip of the neural
tube involves a morphological change from an epithelial cell type
to that of a migratory cell type (Firulli and Conway, 2004; Jung et
al., 2005). A number of different studies have implicated the
Msx1 gene as being amajor player in neural crest cell specification
(Burstyn-Cohen et al., 2004; Monsoro-Burq et al., 2005; Tribulo
et al., 2003) along with members of the SoxE family (Sox 8, 9 and
10 (Kordes et al., 2005)), the Snail family, FoxD3, Lbx1, c-Myc
and Pax3 (Barembaum and Bronner-Fraser, 2005). In the current
study we demonstrate that KE is active in the neural tube dorsal
lip region at E8 which is whereMsx1would need to be expressed
in order to play a role in neural crest specification. Thus, the high
degrees of evolutionary conservation of the KE element, the
putative transcription factor binding sites contained within it and
its activity in the early dorsal neural tube lip supports a role for
Msx1 in the specification of cardiac neural crest.In addition to being expressed in the neural plate dorsal lip
during neural crest specification,Msx1 continues to be expressed
in neural crest cells undergoing migration in chick embryos
(Taneyhill and Bronner-Fraser, 2005) an observation confirmed
in mammalian embryos in the current study. Further evidence
comes from previous examinations of the expression of a LacZ
marker gene used to target the Msx1 locus where it was shown
that LacZ activity was present within migrating neural crest cells
derived from rhombomeres 4 and 6 (Houzelstein et al., 1997).
Based on this existing literature and the findings described here
we propose that the KE element is required to support the
expression of the Msx1 gene within cardiac neural crest cells
during their specification and migration where Msx1, in its role
as a potent antagonist of cell differentiation (Odelberg et al.,
2000; Thompson-Jaeger and Raghow, 2000), may be required to
act as a brake to differentiation thus supporting cell migration.
The mechanism through which Msx1 achieves this might
involve a direct interaction with the Pax3 protein that is also
expressed in dorsal neural tube lip and migrating cNC and is also
known to be required for cNC specification (Epstein et al.,
2000). Msx1 and Pax3 have been shown to cooperate in the
specification of neural crest (Monsoro-Burq et al., 2005). In
addition, previous studies have suggested that within other organ
systems the Msx1 protein prevents cellular differentiation by
directly binding to the Pax3 protein (Bendall et al., 1999;
Bendall et al., 1998). Such a relationship between Pax3 and
Msx1 may also exist within migrating cardiac neural crest cells
where Pax3 may be required to specify cNC (Epstein et al.,
2000) but whereMsx1 is required to modulate this activity of the
Pax3 protein thus allowing cell migration.
We have succeeded in detecting the activity of the KE element
in presumptive dorsal neural tube lip cells and in migrating
cardiac neural crest cells, that we show also express Msx1
transcripts at E.10.5, consistent with a role for KE in supporting
Msx1 expression during cNC specification and migration.
However, the observed activity of KE in the developing
endocardiac cushions during formation of the outflow tract was
less conclusive. For example, Msx1 is strongly expressed in the
endocardiac cushions from E10.5 onwards but we were unable to
detect activity of KE within the outflow tract until E11.5. These
observations suggest that, although important for Msx1 expres-
sion in the specification and migration of cNC, KE may not play
such an important role in the expression ofMsx1 in differentiating
endocardiac cushions. A number of studies have demonstrated
that the expression of theMsx1 gene during the morphogenesis of
the limb buds and neural tube roof plate is associated with, and is
supported by, the expression of bone morphogenic proteins
(BMPs) (Lallemand et al., 2005). In addition, there have been a
number of studies which suggest that the expression of the Msx
genes in the endocardial cushions of the differentiating heart
outflow tract is supported by BMP mediated regulatory systems
(Abdelwahid et al., 2001; Angello et al., 2006; Eisenberg and
Markwald, 1995). Thus, we hypothesise that at least two
enhancers are required for the expression of Msx1 during the
development of the OFT. We believe that we have identified one
of these enhancers in the form of the highly conserved and cAMP
dependent KE element that may be required for expression of
693K.A. Miller et al. / Developmental Biology 317 (2008) 686–694Msx1 during early specification and migration of cNC cells.
Thus, the requirement for expression of Msx1 in migrating cNC
is an ancient one and is reflected by the exceptional degrees of
KE conservation. However, we believe that a second enhancer,
that supports Msx1 in the endocardiac cushions during their
differentiation, remains to be identified. We hypothesise that this
second enhancer is likely to be BMP dependent and is required
for Msx1 expression in the endocardiac cushions. We would
further venture that this second enhancer will not be so easy to
identify as it will not be as highly conserved as KE. This lack of
conservation will reflect its role in the later stages of the
morphogenesis of the mammalian outflow tract that is a
comparatively recent adaptation within the hearts of birds and
mammals from an evolutionary perspective. We are currently
extending our analysis to determine the possible location of this
element.
Although Msx1 has been shown to be expressed in cardiac
neural crest during their specification, migration and differentia-
tion and is, together with Msx2, critical for normal morphogen-
esis of OFT, the precise stage at which these genes are most
crucial to OFT development remains to be determined. The
requirement forMsx1 in the specification and migration of cNC
cells is suggested by the extreme conservation of the KE element
which our studies suggest supports expression of Msx1 in cNC
cells during these stages. This observation is not without
precedence as although it has been shown that the Pax3 gene is
essential for the normal formation of the OFT migrating cNC
cells stop expressing Pax3 before their arrival in the heart
(Epstein et al., 2000). Thus it is entirely feasible that because the
requirement for the expression ofMsx1 in the dorsal neural tube
lip and in migrating cardiac neural crest cells precludes the
expression of Msx1 in cardiac outflow tract that expression of
Msx1 in dorsal lip and migrating cNC represent the most
important stages of Msx1 expression required for normal heart
development. Therefore, concentrating exclusively on the regu-
latory mechanisms governing the expression of Msx1 in the
endocardial cushions may be a mistake as many outflow tract
defects might result from problems in the specification and mig-
ration of cNC rather than the formation of endocardial cushions.
It has been largely accepted that theMsx1 protein is a classic
transcription factor that influences gene activity through DNA
binding. The two mouse Msx1 gene deletion models previously
produced reflected this belief and, in both cases, only sequence
3′ and including the third helix of the homeodomain were
deleted leaving the rest of the homeodomain intact (Houzelstein
et al., 1997; Satokata and Maas, 1994). More recent evidence
now suggests that another mode of action of the Msx1 protein
includes protein–protein interactions with other transcription
factor proteins such as the Pax, Dlx and Lhx genes via the N-
terminus and the first helix of the homoedomain (Bendall et al.,
1998, 1999; Bryan and Morasso, 2000; Zhang et al., 1997).
Thus, existing Msx1 targeted deletion models may not fully
reflect the developmental significance of the Msx1 gene in the
inhibition of gene expression through protein–protein interac-
tion with known cNC specification factors such as Lhx1 and
Pax3. This possibility warrants further analysis through the
production of a complete Msx1 null mouse model.Conclusions
OFT defects make up one of the most frequent class of birth
defects affecting newborn infants. Understanding the causes of
susceptibility to OFT defects through genetic analysis of patient
DNA through linkage and association studies of DNA
polymorphisms is one of the most important directions we
can take towards understanding how outflow tract defects occur.
Until recently, however, much of the effort into understanding
the causes of OFT defects has been directed against the coding
regions of genes. The current study highlights the extreme
conservation of a regulatory element responsible for supporting
the expression of a gene known to be involved in OFT
formation and underlines the need to look at regulatory regions,
as well as coding regions when looking for the polymorphisms
that affect susceptibility to OFT defects.
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